185 related articles for article (PubMed ID: 30629324)
1. Patterns of recurrence and retreatment outcomes among clinical stage I and II head and neck melanoma patients.
Namin AW; Cornell GE; Thombs LA; Zitsch RP
Head Neck; 2019 May; 41(5):1304-1311. PubMed ID: 30629324
[TBL] [Abstract][Full Text] [Related]
2. Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.
Sun L; Chin RI; Gastman B; Thorstad W; Yom SS; Reddy CA; Nussenbaum B; Wang SJ; Knackstedt T; Vidimos AT; Koyfman SA; Manyam BV
JAMA Dermatol; 2019 Apr; 155(4):442-447. PubMed ID: 30810715
[TBL] [Abstract][Full Text] [Related]
3. Patterns of failure and predictors of outcome in cutaneous malignant melanoma of the scalp.
Terakedis BE; Anker CJ; Leachman SA; Andtbacka RH; Bowen GM; Sause WT; Grossmann KF; Bowles TL; Noyes RD; Hitchcock YJ; Boucher KM; Shrieve DC
J Am Acad Dermatol; 2014 Mar; 70(3):435-42. PubMed ID: 24373782
[TBL] [Abstract][Full Text] [Related]
4. Recurrence of cutaneous melanoma of the head and neck after negative sentinel lymph node biopsy.
Davis-Malesevich MV; Goepfert R; Kubik M; Roberts DB; Myers JN; Kupferman ME
Head Neck; 2015 Aug; 37(8):1116-21. PubMed ID: 24764188
[TBL] [Abstract][Full Text] [Related]
5. Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data.
Smith VA; Camp ER; Lentsch EJ
Laryngoscope; 2012 Jun; 122(6):1283-90. PubMed ID: 22522673
[TBL] [Abstract][Full Text] [Related]
6. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
Fairbairn NG; Orfaniotis G; Butterworth M
J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
[TBL] [Abstract][Full Text] [Related]
8. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
[TBL] [Abstract][Full Text] [Related]
9. Performance of a 31-gene expression profile test in cutaneous melanomas of the head and neck.
Gastman BR; Zager JS; Messina JL; Cook RW; Covington KR; Middlebrook B; Gerami P; Wayne JD; Leachman S; Vetto JT
Head Neck; 2019 Apr; 41(4):871-879. PubMed ID: 30694001
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy in thick malignant melanoma: A 16-year single unit experience.
Hunger RE; Michel A; Seyed Jafari SM; Shafighi M
Eur J Dermatol; 2015; 25(5):472-6. PubMed ID: 26394835
[TBL] [Abstract][Full Text] [Related]
11. Surgery and adjuvant radiotherapy for cutaneous melanoma considered high-risk for local-regional recurrence.
Mendenhall WM; Shaw C; Amdur RJ; Kirwan J; Morris CG; Werning JW
Am J Otolaryngol; 2013; 34(4):320-2. PubMed ID: 23375588
[TBL] [Abstract][Full Text] [Related]
12. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
[TBL] [Abstract][Full Text] [Related]
13. Risk and Survival of Patients with Head and Neck Cutaneous Melanoma: National Perspective.
Al-Qurayshi Z; Hassan M; Srivastav S; Sperry S; Pagedar N; Hamner J; Kandil E
Oncology; 2017; 93(1):18-28. PubMed ID: 28423377
[TBL] [Abstract][Full Text] [Related]
14. Head and neck desmoplastic melanoma: Utility of sentinel node biopsy.
Sims JR; Wieland CN; Kasperbauer JL; Moore EJ; Price DL
Am J Otolaryngol; 2017; 38(5):537-541. PubMed ID: 28662971
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma.
Andtbacka RH; Agarwala SS; Ollila DW; Hallmeyer S; Milhem M; Amatruda T; Nemunaitis JJ; Harrington KJ; Chen L; Shilkrut M; Ross M; Kaufman HL
Head Neck; 2016 Dec; 38(12):1752-1758. PubMed ID: 27407058
[TBL] [Abstract][Full Text] [Related]
16. Wide local excision prior to sentinel lymph node biopsy for primary melanoma of the head and neck.
May MM; Lohse CM; Moore EJ; Price DL; Van Abel KM; Brewer JD; Janus JR
Int J Dermatol; 2019 Oct; 58(10):1184-1190. PubMed ID: 30968948
[TBL] [Abstract][Full Text] [Related]
17. Survival and Surgical Outcomes for Pediatric Head and Neck Melanoma.
Richards MK; Czechowicz J; Goldin AB; Gow KW; Doski J; Goldfarb M; Nuchtern J; Langer M; Beierle EA; Vasudevan S; Gupta D; Parikh SR
JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):34-40. PubMed ID: 27607058
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result.
Jones EL; Jones TS; Pearlman NW; Gao D; Stovall R; Gajdos C; Kounalakis N; Gonzalez R; Lewis KD; Robinson WA; McCarter MD
JAMA Surg; 2013 May; 148(5):456-61. PubMed ID: 23325294
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of 39 cases of pediatric cutaneous head and neck melanoma.
Tcheung WJ; Marcello JE; Puri PK; Abernethy AP; Nelson KC
J Am Acad Dermatol; 2011 Aug; 65(2):e37-e42. PubMed ID: 21075477
[TBL] [Abstract][Full Text] [Related]
20. Malignant melanoma of the skin: long-term follow-up and time to first recurrence.
Hohnheiser AM; Gefeller O; Göhl J; Schuler G; Hohenberger W; Merkel S
World J Surg; 2011 Mar; 35(3):580-9. PubMed ID: 21125274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
